Malik-Soni, Natasha
Shaker, Andrew
Luck, Helen
Mullin, Anne E.
Wiley, Ryan E.
Lewis, M. E. Suzanne
Fuentes, Joaquin
Frazier, Thomas W.
Article History
Received: 21 July 2020
Revised: 21 December 2020
Accepted: 23 February 2021
First Online: 25 March 2021
Competing interests
: T.W.F. has received funding or research support from, acted as a consultant to, received travel support from, and/or received a speaker’s honorarium from Quadrant Biosciences, Impel NeuroPharma, F. Hoffmann-La Roche AG Pharmaceuticals, the Cole Family Research Fund, Simons Foundation, Ingalls Foundation, Forest Laboratories, Ecoeos, IntegraGen, Kugona LLC, Shire Development, Bristol-Myers Squibb, Roche Pharma, National Institutes of Health, and the Brain and Behavior Research Foundation and has an investor stake in Autism EYES LLC. J.F. has received research support from Policlinica Gipuzkoa Foundation (PGF), Servier, and AIMS-2 Trials/Project ID 777394. He has received partial support for professional meetings attendance from PGF, ESCAP & AACAP.
: Not required for this study.
Free to read: This content has been made available to all.